Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dexter

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
The Journal of Pharmacy and Pharmacology|May 15, 2004
The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's diseaseK P Datla, R D Bennett, V Zbarsky, et al.
Annals of Neurology|October 1, 1992
Alpha-tocopherol levels in brain are not altered in Parkinson's diseaseD T Dexter, R J Ward, F R Wells, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2010
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administrationDavid T Dexter, Sarah A Statton, Charlotte Whitmore, et al.
Neuropathology and Applied Neurobiology|April 12, 2001
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitroH K Rooprai, A Kandanearatchi, S L Maidment, et al.
Journal of Neurochemistry|July 1, 1990
Decreased ferritin levels in brain in Parkinson's diseaseD T Dexter, A Carayon, M Vidailhet, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2020
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian RatsPuneet K Sharma, Lisa Wells, Gaia Rizzo, et al.
Brain : a Journal of Neurology|August 1, 1991
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal gangliaD T Dexter, A Carayon, F Javoy-Agid, et al.
ACS Applied Materials & Interfaces|October 24, 2017
Multibranched Gold Nanoparticles with Intrinsic LAT-1 Targeting Capabilities for Selective Photothermal Therapy of Breast CancerZhan Yuin Ong, Shu Chen, Elham Nabavi, et al.
Acta Neuropathologica|January 5, 2007
Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigraL B Moran, E Croisier, D C Duke, et al.
Annals of Neurology|March 1, 1994
Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studiesD T Dexter, D J Brooks, A E Harding, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacy and Pharmacology|May 15, 2004
The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's diseaseK P Datla, R D Bennett, V Zbarsky, et al.
Annals of Neurology|October 1, 1992
Alpha-tocopherol levels in brain are not altered in Parkinson's diseaseD T Dexter, R J Ward, F R Wells, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2010
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administrationDavid T Dexter, Sarah A Statton, Charlotte Whitmore, et al.
Neuropathology and Applied Neurobiology|April 12, 2001
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitroH K Rooprai, A Kandanearatchi, S L Maidment, et al.
Journal of Neurochemistry|July 1, 1990
Decreased ferritin levels in brain in Parkinson's diseaseD T Dexter, A Carayon, M Vidailhet, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2020
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian RatsPuneet K Sharma, Lisa Wells, Gaia Rizzo, et al.
Brain : a Journal of Neurology|August 1, 1991
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal gangliaD T Dexter, A Carayon, F Javoy-Agid, et al.
ACS Applied Materials & Interfaces|October 24, 2017
Multibranched Gold Nanoparticles with Intrinsic LAT-1 Targeting Capabilities for Selective Photothermal Therapy of Breast CancerZhan Yuin Ong, Shu Chen, Elham Nabavi, et al.
Acta Neuropathologica|January 5, 2007
Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigraL B Moran, E Croisier, D C Duke, et al.
Annals of Neurology|March 1, 1994
Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studiesD T Dexter, D J Brooks, A E Harding, et al.
Pageof 14